Transferrin receptor binding molecules, their conjugates, and their use for the prevention or treatment of neurological disorders.

JP2026521070APending Publication Date: 2026-06-25VECTOR-ALL +2
View PDF 6 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
VECTOR-ALL
Filing Date
2024-06-21
Publication Date
2026-06-25

Smart Images

  • Figure 2026521070000052
    Figure 2026521070000052
  • Figure 2026521070000053
    Figure 2026521070000053
  • Figure 2026521070000054
    Figure 2026521070000054
Patent Text Reader

Abstract

The present invention relates to variable domains (VHHs) of camelid heavy chain molecules that bind to TfR, conjugate compounds containing such VHH molecules, and their use for, for example, transporting molecules for pharmaceutical purposes to cells and organs in pathological conditions in the CNS or PNS, including cancer.
Need to check novelty before this filing date? Find Prior Art